Ovarian Cancer Trial, Recruiting NCT06969833 Sponsor: Centre Oscar Lambret Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06969833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have given informed consent to participate
  • People enrolled in a French social security scheme
  • People with a suspected diagnosis of advanced ovarian cancer, primary peritoneal cancer, and/or fallopian tube cancer at a certain stage of progression (stages IIB to IV according to the international FIGO staging system)
  • People who are registered during standard care at the Oscar Lambret Centre, from the point of initial diagnosis and before a final confirmed stage is determined
  • People who have received a confirmed diagnosis of advanced ovarian cancer, primary peritoneal cancer, and/or fallopian tube cancer (stages IIB to IV)

Who may not be able to join:

  • People who are currently in legal detention, or who are under legal protection measures such as curatorship or guardianship
  • People who do not wish to participate in the trial
  • People whose suspected diagnosis has been ruled out, or who are found to have a different type of cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33320295918

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Oscar Lambret
Registry
ClinicalTrials.gov
Start date
27 June 2025
Est. completion
27 June 2032

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To identify prognostic factors associated with overall survival on patients included prospectively as part of the initial treatment integrating both patient's and tumor's characteristics, using a multivariate Cox model.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov